ATE124952T1 - Haloethyl substituierte enzymhemmende steroiden. - Google Patents

Haloethyl substituierte enzymhemmende steroiden.

Info

Publication number: ATE124952T1
Authority: AT; Austria
Prior art keywords: enzyme inhibiting; haloethyl; inhibiting steroids; substituted enzyme; haloethyl substituted
Prior art date: 1990-04-02

Application number

AT91105003T

Other languages

English (en)

Inventor

Joseph P Burkhart

Norton P Peet

J O'neal Johnston

Original Assignee

Merrell Dow Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-04-02

Filing date

1991-03-28

Publication date

1995-07-15

1991-03-28 Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma

1995-07-15 Application granted granted Critical

1995-07-15 Publication of ATE124952T1 publication Critical patent/ATE124952T1/de

Links

102000004190 Enzymes Human genes 0.000 title 1
108090000790 Enzymes Proteins 0.000 title 1
230000002401 inhibitory effect Effects 0.000 title 1
150000003431 steroids Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 abstract 1
PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 abstract 1
102000014654 Aromatase Human genes 0.000 abstract 1
108010078554 Aromatase Proteins 0.000 abstract 1
229960002478 aldosterone Drugs 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
239000002532 enzyme inhibitor Substances 0.000 abstract 1
125000004969 haloethyl group Chemical group 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
230000003637 steroidlike Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/008—Ketals at position 17
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Hematology (AREA)
Obesity (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Toxicology (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)
Paper (AREA)

AT91105003T 1990-04-02 1991-03-28 Haloethyl substituierte enzymhemmende steroiden. ATE124952T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US50319190A	1990-04-02	1990-04-02

Publications (1)

Publication Number	Publication Date
ATE124952T1 true ATE124952T1 (de)	1995-07-15

Family

ID=24001090

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91105003T ATE124952T1 (de)	1990-04-02	1991-03-28	Haloethyl substituierte enzymhemmende steroiden.

Country Status (17)

Country	Link
EP (1)	EP0450515B1 (de)
JP (1)	JP3058710B2 (de)
KR (1)	KR0186004B1 (de)
CN (1)	CN1055365A (de)
AT (1)	ATE124952T1 (de)
AU (1)	AU636023B2 (de)
CA (1)	CA2038985C (de)
DE (1)	DE69111108T2 (de)
ES (1)	ES2077097T3 (de)
FI (1)	FI911529L (de)
HU (1)	HUT57232A (de)
IE (1)	IE911062A1 (de)
IL (1)	IL97696A0 (de)
NO (1)	NO911236L (de)
NZ (1)	NZ237559A (de)
PT (1)	PT97202A (de)
ZA (1)	ZA912235B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4433374A1 (de) *	1994-09-20	1996-03-21	Hoechst Ag	17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3213085A (en) *	1962-06-12	1965-10-19	Syntex Corp	19-lower alkyl-delta4-pregnen-20-one derivatives
US3449381A (en) *	1962-06-12	1969-06-10	Syntex Corp	19-oxo- and 19-lower alkyl-19-oxoandrostane derivatives
GB8531747D0 (en) *	1985-12-24	1986-02-05	Erba Farmitalia	10beta-alkynylestrene derivatives
GB8531743D0 (en) *	1985-12-24	1986-02-05	Erba Farmitalia	10beta-halo-alkynyl-estrene derivatives

1991
- 1991-03-25 ZA ZA912235A patent/ZA912235B/xx unknown
- 1991-03-25 CA CA002038985A patent/CA2038985C/en not_active Expired - Fee Related
- 1991-03-25 NZ NZ237559A patent/NZ237559A/xx unknown
- 1991-03-26 AU AU73784/91A patent/AU636023B2/en not_active Ceased
- 1991-03-26 NO NO91911236A patent/NO911236L/no unknown
- 1991-03-27 IL IL97696A patent/IL97696A0/xx unknown
- 1991-03-28 FI FI911529A patent/FI911529L/fi unknown
- 1991-03-28 PT PT97202A patent/PT97202A/pt not_active Application Discontinuation
- 1991-03-28 IE IE106291A patent/IE911062A1/en unknown
- 1991-03-28 EP EP91105003A patent/EP0450515B1/de not_active Expired - Lifetime
- 1991-03-28 DE DE69111108T patent/DE69111108T2/de not_active Expired - Fee Related
- 1991-03-28 AT AT91105003T patent/ATE124952T1/de not_active IP Right Cessation
- 1991-03-28 ES ES91105003T patent/ES2077097T3/es not_active Expired - Lifetime
- 1991-03-29 HU HU911038A patent/HUT57232A/hu unknown
- 1991-03-30 KR KR1019910005136A patent/KR0186004B1/ko not_active Expired - Fee Related
- 1991-04-01 CN CN91102036A patent/CN1055365A/zh active Pending
- 1991-04-02 JP JP3094976A patent/JP3058710B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN1055365A (zh)	1991-10-16
CA2038985A1 (en)	1991-10-03
ZA912235B (en)	1991-12-24
HU911038D0 (en)	1991-10-28
JP3058710B2 (ja)	2000-07-04
DE69111108T2 (de)	1996-01-18
FI911529A7 (fi)	1991-10-03
IL97696A0 (en)	1992-06-21
PT97202A (pt)	1991-11-29
NO911236D0 (no)	1991-03-26
EP0450515A3 (en)	1992-09-30
ES2077097T3 (es)	1995-11-16
FI911529A0 (fi)	1991-03-28
EP0450515A2 (de)	1991-10-09
AU636023B2 (en)	1993-04-08
IE911062A1 (en)	1991-10-09
HUT57232A (en)	1991-11-28
FI911529L (fi)	1991-10-03
NO911236L (no)	1991-10-03
EP0450515B1 (de)	1995-07-12
JPH04253994A (ja)	1992-09-09
KR910018402A (ko)	1991-11-30
CA2038985C (en)	2002-10-15
KR0186004B1 (ko)	1999-04-01
AU7378491A (en)	1991-10-03
NZ237559A (en)	1993-04-28
DE69111108D1 (de)	1995-08-17

Legal Events

Date	Code	Title	Description
1996-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69516866D1 (de)	2000-06-15	Stereochemische wortmanninderivate
ES2106965T3 (es)	1997-11-16	Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa.
DK0599444T3 (da)	1998-09-21	Dobbeltvirkende inhibitorer
PT1040108E (pt)	2004-06-30	Derivados de orto-antranilamida como anticoagulantes
KR100321018B1 (ko)	2002-03-20	스테로이드 설파타제 억제제인 정제된 화합물
DK0515544T3 (da)	1996-02-12	Steroidsulfataseinhibitorer
DE69709938D1 (de)	2002-02-28	N-benzylpiperidin- und tetrahydropyridin-derivate
ATE290382T1 (de)	2005-03-15	Heterozyklische kalium-kanal inhibitoren
DK279790A (da)	1990-11-23	Aromatiske steroid-5-alfa-reduktaseinhibitorer
KR960705838A (ko)	1996-11-08	스테로이드 C17-20 리아제 억제제로서 유용한 △16 불포화 C17 헤테로사이클릭 스테로이드(△16 Unsaturated C17 heterocyclic steroids useful as steroid C17-20 lyase inhibitors)
ATE451107T1 (de)	2009-12-15	3-o-sulfamatsteroidderivate als hemmer von estronsulfatase
BR9713951A (pt)	2000-03-21	Processo para preparação de 3-hidroxipirazóis n-substituìdos.
ATE30429T1 (de)	1987-11-15	Acylamino-oxo- oder hydroxy-substituiertealkylamino thiazine und thiazepine.
DE69111108D1 (de)	1995-08-17	Haloethyl substituierte enzymhemmende Steroiden.
NO943765L (no)	1995-04-10	Aryloksybenzen-herbicidmidler
FI915623A0 (fi)	1991-11-28	2b,19-etylenbryggsteroider som aromatasinhibitorer.
ES8205126A1 (es)	1982-06-01	Un procedimiento para la preparacion de un inhibidor del enzima convertidor de la angiotensina.
NO912985D0 (no)	1991-07-31	Forbedret system for transdermal applikasjon av farmasoeytisk aktive forbindelser ved regulert ph.
ES2076286T3 (es)	1995-11-01	Esteroides con puente 2,19-metilenoxi y 2,19-metilentio utiles como inhibidores de aromatasa y 19-hidroxilasa.
ES2173634T3 (es)	2002-10-16	Compuestos heterociclicos que presentan actividad inhibidora de mmp y tnf.
ZA973985B (en)	1997-12-09	Iminoxy derivatives of fenamate compounds as inhibitors of prostaglandin biosynthesis.
FI943835L (fi)	1994-08-19	Välituotteet käytettäväksi steroidi-5-alfa-reduktaasin inhibiittoreiden valmistamiseksi